Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

Opioid Investigated to Treat Acute & Chronic OA Pain; Plus New RA Treatment & More

Michele B. Kaufman, PharmD, BCGP  |  January 20, 2016

In Phase 2 trials, the oral opioid, CR845, has proved promising in treating pain in patients with hip and knee osteoarthritis. Olokizumab is being investigated to treat RA, and in Canada, adalimumab has been approved to treat polyarticular JIA in 2–4 year-olds…

Filed under:AnalgesicsConditionsDrug UpdatesPain Syndromes Tagged with:adalimumabCanadaChronic painchronic pruritushiphip painInternationalKnee Osteoarthritis (OA)olokizumabOsteoarthritisPainRheumatoid Arthritis (RA)

Rheumatology Research Foundation Launches Honorary Board of Advisors

From the College  |  January 19, 2016

Nearly 150 of the Rheumatology Research Foundation’s most generous supporters gathered in November during the 2015 ACR/ARHP Annual Meeting for the Donors of Merit recognition event. In celebration of the Foundation’s 30th Anniversary in 2015, the event reflected on the journey to advance treatments and improve patient care. The Foundation’s president, David Karp, MD, PhD,…

Filed under:From the CollegeResearch Rheum Tagged with:Rheumatology Research Foundation

Set Realistic Career Goals to Reach Your Professional Potential

Set Realistic Career Goals to Reach Your Professional Potential

Karen Appold  |  January 19, 2016

As a rheumatologist, you’re used to having goals. After all, you set your sights on becoming a physician, achieved the necessary educational degrees and passed required exams. After meeting your educational goals, you landed a job at an academic medical center or an established rheumatology practice, or you may have started your own practice. So…

Filed under:Career DevelopmentProfessional Topics Tagged with:Careergoalphysicianprofessionalrheumatologist

The Lupus Initiative Launches Cohorts & Partnerships to Reduce Health Disparities & Improve Outcomes

From the College  |  December 23, 2015

The Lupus Initiative (TLI) of the American College of Rheumatology (ACR) continues its work to reduce the health disparities for people with lupus through multiple, national-level, grant-funded projects, targeting primary care physicians with lupus education to increase appropriate rheumatology referrals and—when necessary, appropriate and effective—distance-managed care. Since 2009, the ACR has received funding through the…

Filed under:ConditionsFrom the CollegeSystemic Lupus Erythematosus Tagged with:AdvocacyAmerican College of Rheumatology (ACR)LupusLupus InitiativeThe Lupus Initiative (TLI)

Rheumatology Research Foundation’s Partnership with CRT Allows for Investment in Research, Training

From the College  |  December 15, 2015

The Rheumatology Research Foundation has infused more than $130 million into rheumatology research, education and training since it was established in 1985. The Foundation’s efforts have been greatly enhanced by the support of Corporate Roundtable (CRT) members. The CRT is a dynamic partnership between the Foundation and members of the pharmaceutical industry committed to furthering…

Filed under:Career DevelopmentEducation & TrainingFrom the CollegeProfessional TopicsResearch Rheum Tagged with:ACR/ARHPAssociation of Rheumatology Professionals (ARP)Corporate RoundtableResearchrheumatologyRheumatology Research FoundationTraining

FDA Approves 2 Pain Drugs & New Gout Treatment on Road to Approval

Michele B. Kaufman, PharmD, BCGP  |  November 18, 2015

The FDA has approved two drugs designed to manage pain: buprenorphine for chronic pain and meloxicam capsules for OA pain. Lesurinad is also closer to FDA approval for treating gout…

Filed under:AnalgesicsBiologics/DMARDsDrug Updates

Rheumatology Research Foundation Scholarships Help Students Attend ACR/ARHP Annual Meeting

Thomas R. Collins  |  November 17, 2015

Seven students pursuing rheumatology-related careers will head to San Francisco in November on a Student and Resident ACR/ARHP Annual Meeting Scholarship—awards that are open to students and residents from states that are underserved by rheumatology professionals. The Rheumatology Research Foundation has awarded the students $750–1,500 toward travel expenses and registration for the ACR/ARHP Annual Meeting,…

Filed under:Career DevelopmentEducation & TrainingProfessional TopicsResearch Rheum Tagged with:ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)medical studentsresidentsRheumatology Research FoundationSan FranciscoScholarship

Rheumatology Coding Corner Answer: Proper Coding for Post-Traumatic Osteoarthritis

From the College  |  November 17, 2015

CPT: 99213, 73500-RT, 73500-LT ICD-10: M16.52 This E/M service entailed: The history is detailed; The examination is expanded problem focused; and The medical decision making is of low complexity. The X-ray reviewed was for radiologic examination, hip, unilateral: one view for the left hip and for the right hip. M16.52—The diagnosis identifies unilateral post-traumatic osteoarthritis…

Filed under:Billing/CodingConditionsOsteoarthritis and Bone DisordersPractice Support Tagged with:BillingCodinghipOsteoarthritisPractice Managementrheumatologist

Rheumatology Coding Corner Question: Coding for Post-Traumatic Osteoarthritis

From the College  |  November 17, 2015

Post-Traumatic OA A 70-year-old female patient comes in for a follow-up visit for pain and stiffness in her left hip. She injured her hip in a skiing accident three years before and reports the X-rays at that time showed no fractures. Due to no obvious fracture at the time, she was given ibuprofen and advised…

Filed under:Billing/CodingConditionsOsteoarthritis and Bone DisordersPractice Support Tagged with:BillingCodinghipOsteoarthritisPractice Managementrheumatologist

Survey: Patient-Doctor Relationship Can Positively Affect RA Management

Linda Childers  |  October 14, 2015

A new survey of more than 3,600 adults living with rheumatoid arthritis (RA) shows that a patient’s perception of their disease and treatment, as well as their relationship with their healthcare professional, can positively impact the management of their disease. The RA NarRAtive survey, created and sponsored by Pfizer, is part of an international initiative…

Filed under:ConditionsPractice SupportRheumatoid Arthritis Tagged with:Clinicalpatient carephysicianPractice ManagementRARheumatoid arthritisrheumatologistrhuematologyTreatment

  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 329
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences